Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: Steven C. Vartan who wrote (2341)	12/2/1998 10:04:00 PM
From: BWAC	Read Replies (1) \| Respond to of 2553

Would anybody in their right mind sell at 2 1/2 solely for tax purposes. I mean chances are that you won't be able to buy back at 2 1/2, assuming you wanted to. You might lose a 100% gain from here trying to delay paying some tax. Last I checked GENZL has 2 approved products, carticel and epicel, that we know are good but as of yet not profitable. And we have the hope that an arthroscopic procedure will make carticel more widely used. This is either the buy of the century or the biggest bust I've ever seen.